President Trump’s planned pharmaceutical tariffs threaten to hit many of the most common and well-known drugs that Americans ...

Biosimilar Market was estimated at USD 31.20 Bn in 2024 and is expected to grow at a CAGR of 17.4% from 2025 to 2032, reaching nearly USD 112.59 Bn by 2032. Biosimilars are redefining access to ...